Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcγRII expression in patients with chronic inflammatory neuropathies

We studied the expression of different lymphocyte and monocyte cellular determinants involved in leukodiapedesis and antigen presentation in 10 patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) with persistent conduction blocks befor...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroimmunology 2003-02, Vol.135 (1), p.91-95
Main Authors: Créange, A, Gregson, N.A, Hughes, R.A.C
Format: Article
Language:English
Subjects:
Inflammatory neuropathy
Integrins
Intravenous immunoglobulin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c338t-c8454cc854137c070771cd427863f43b992eaa5f5fa833dc0a52448917b98b03
cites cdi_FETCH-LOGICAL-c338t-c8454cc854137c070771cd427863f43b992eaa5f5fa833dc0a52448917b98b03
container_end_page 95
container_issue 1
container_start_page 91
container_title Journal of neuroimmunology
container_volume 135
creator Créange, A
Gregson, N.A
Hughes, R.A.C
description We studied the expression of different lymphocyte and monocyte cellular determinants involved in leukodiapedesis and antigen presentation in 10 patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) with persistent conduction blocks before intravenous immunoglobulin (IVIg), immediately after infusion of IVIg and 1 week after infusion. We observed a decrease of T lymphocytes expressing ICAM-1 (CD54) immediately after infusion in 8 out of 10 patients ( p
doi_str_mv 10.1016/S0165-5728(02)00430-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18687643</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165572802004307</els_id><sourcerecordid>18687643</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-c8454cc854137c070771cd427863f43b992eaa5f5fa833dc0a52448917b98b03</originalsourceid><addsrcrecordid>eNqFkM1OGzEQx62qSE2hj1DJp6octthrO_aeEApQIiEh0dwtxzvbuNq1F9ubkifggXgPnqkOqbhymZHm_yHND6GvlPyghM7PfpUhKiFr9Z3Up4RwRir5Ac2oknWleE0_otmb5RP6nNIfQqhgvJmhp6XP0WzBhylhNwyTD7_7sJ565_EQ2qk3GRLud8O4CXaXAS8uBcfGt0X1h8u1fXm-Xy4xPI4RUnLB4xIeTXbgc8J_Xd5gu4nBO1uErjfDYHKIO-xhiqH4Ng7SCTrqTJ_gy_99jFbXV6vFTXV793O5uLitLGMqV1Zxwa1VglMmLZFESmpbXks1Zx1n66apwRjRic4oxlpLjKg5Vw2V60atCTtG3w61YwwPE6SsB5cs9L3xUAhoquZKzjkrRnEw2hhSitDpMbrBxJ2mRO-p61fqeo9Uk1q_Utey5M4POShPbB1EnWzhYKF1EWzWbXDvNPwD2d6NXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18687643</pqid></control><display><type>article</type><title>Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcγRII expression in patients with chronic inflammatory neuropathies</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Créange, A ; Gregson, N.A ; Hughes, R.A.C</creator><creatorcontrib>Créange, A ; Gregson, N.A ; Hughes, R.A.C</creatorcontrib><description>We studied the expression of different lymphocyte and monocyte cellular determinants involved in leukodiapedesis and antigen presentation in 10 patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) with persistent conduction blocks before intravenous immunoglobulin (IVIg), immediately after infusion of IVIg and 1 week after infusion. We observed a decrease of T lymphocytes expressing ICAM-1 (CD54) immediately after infusion in 8 out of 10 patients ( p&lt;0.04) with a return to pretreatment values after 1 week. The monocytes showed an increase in CD14 + cells and CD14 + FcγRII inhibitory receptor positive cells, no change in the number of CD14 + FcγRIII activation receptor cells, and an increase in the FcγRII/FcγRIII ratio on monocytes 1 week after IVIg. Thus, the mechanism of action of IVIg in both CIDP and MMN may involve inhibition of T cell transmigration and modulation of antigen presentation capacities through FcγR expression.</description><identifier>ISSN: 0165-5728</identifier><identifier>EISSN: 1872-8421</identifier><identifier>DOI: 10.1016/S0165-5728(02)00430-7</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Inflammatory neuropathy ; Integrins ; Intravenous immunoglobulin</subject><ispartof>Journal of neuroimmunology, 2003-02, Vol.135 (1), p.91-95</ispartof><rights>2002 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c338t-c8454cc854137c070771cd427863f43b992eaa5f5fa833dc0a52448917b98b03</citedby><cites>FETCH-LOGICAL-c338t-c8454cc854137c070771cd427863f43b992eaa5f5fa833dc0a52448917b98b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Créange, A</creatorcontrib><creatorcontrib>Gregson, N.A</creatorcontrib><creatorcontrib>Hughes, R.A.C</creatorcontrib><title>Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcγRII expression in patients with chronic inflammatory neuropathies</title><title>Journal of neuroimmunology</title><description>We studied the expression of different lymphocyte and monocyte cellular determinants involved in leukodiapedesis and antigen presentation in 10 patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) with persistent conduction blocks before intravenous immunoglobulin (IVIg), immediately after infusion of IVIg and 1 week after infusion. We observed a decrease of T lymphocytes expressing ICAM-1 (CD54) immediately after infusion in 8 out of 10 patients ( p&lt;0.04) with a return to pretreatment values after 1 week. The monocytes showed an increase in CD14 + cells and CD14 + FcγRII inhibitory receptor positive cells, no change in the number of CD14 + FcγRIII activation receptor cells, and an increase in the FcγRII/FcγRIII ratio on monocytes 1 week after IVIg. Thus, the mechanism of action of IVIg in both CIDP and MMN may involve inhibition of T cell transmigration and modulation of antigen presentation capacities through FcγR expression.</description><subject>Inflammatory neuropathy</subject><subject>Integrins</subject><subject>Intravenous immunoglobulin</subject><issn>0165-5728</issn><issn>1872-8421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkM1OGzEQx62qSE2hj1DJp6octthrO_aeEApQIiEh0dwtxzvbuNq1F9ubkifggXgPnqkOqbhymZHm_yHND6GvlPyghM7PfpUhKiFr9Z3Up4RwRir5Ac2oknWleE0_otmb5RP6nNIfQqhgvJmhp6XP0WzBhylhNwyTD7_7sJ565_EQ2qk3GRLud8O4CXaXAS8uBcfGt0X1h8u1fXm-Xy4xPI4RUnLB4xIeTXbgc8J_Xd5gu4nBO1uErjfDYHKIO-xhiqH4Ng7SCTrqTJ_gy_99jFbXV6vFTXV793O5uLitLGMqV1Zxwa1VglMmLZFESmpbXks1Zx1n66apwRjRic4oxlpLjKg5Vw2V60atCTtG3w61YwwPE6SsB5cs9L3xUAhoquZKzjkrRnEw2hhSitDpMbrBxJ2mRO-p61fqeo9Uk1q_Utey5M4POShPbB1EnWzhYKF1EWzWbXDvNPwD2d6NXQ</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>Créange, A</creator><creator>Gregson, N.A</creator><creator>Hughes, R.A.C</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope></search><sort><creationdate>20030201</creationdate><title>Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcγRII expression in patients with chronic inflammatory neuropathies</title><author>Créange, A ; Gregson, N.A ; Hughes, R.A.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-c8454cc854137c070771cd427863f43b992eaa5f5fa833dc0a52448917b98b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Inflammatory neuropathy</topic><topic>Integrins</topic><topic>Intravenous immunoglobulin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Créange, A</creatorcontrib><creatorcontrib>Gregson, N.A</creatorcontrib><creatorcontrib>Hughes, R.A.C</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of neuroimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Créange, A</au><au>Gregson, N.A</au><au>Hughes, R.A.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcγRII expression in patients with chronic inflammatory neuropathies</atitle><jtitle>Journal of neuroimmunology</jtitle><date>2003-02-01</date><risdate>2003</risdate><volume>135</volume><issue>1</issue><spage>91</spage><epage>95</epage><pages>91-95</pages><issn>0165-5728</issn><eissn>1872-8421</eissn><abstract>We studied the expression of different lymphocyte and monocyte cellular determinants involved in leukodiapedesis and antigen presentation in 10 patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and multifocal motor neuropathy (MMN) with persistent conduction blocks before intravenous immunoglobulin (IVIg), immediately after infusion of IVIg and 1 week after infusion. We observed a decrease of T lymphocytes expressing ICAM-1 (CD54) immediately after infusion in 8 out of 10 patients ( p&lt;0.04) with a return to pretreatment values after 1 week. The monocytes showed an increase in CD14 + cells and CD14 + FcγRII inhibitory receptor positive cells, no change in the number of CD14 + FcγRIII activation receptor cells, and an increase in the FcγRII/FcγRIII ratio on monocytes 1 week after IVIg. Thus, the mechanism of action of IVIg in both CIDP and MMN may involve inhibition of T cell transmigration and modulation of antigen presentation capacities through FcγR expression.</abstract><pub>Elsevier B.V</pub><doi>10.1016/S0165-5728(02)00430-7</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-5728
ispartof Journal of neuroimmunology, 2003-02, Vol.135 (1), p.91-95
issn 0165-5728
1872-8421
language eng
recordid cdi_proquest_miscellaneous_18687643
source ScienceDirect Freedom Collection 2022-2024
subjects Inflammatory neuropathy
Integrins
Intravenous immunoglobulin
title Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcγRII expression in patients with chronic inflammatory neuropathies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A23%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20immunoglobulin%20modulates%20lymphocyte%20CD54%20and%20monocyte%20Fc%CE%B3RII%20expression%20in%20patients%20with%20chronic%20inflammatory%20neuropathies&rft.jtitle=Journal%20of%20neuroimmunology&rft.au=Cr%C3%A9ange,%20A&rft.date=2003-02-01&rft.volume=135&rft.issue=1&rft.spage=91&rft.epage=95&rft.pages=91-95&rft.issn=0165-5728&rft.eissn=1872-8421&rft_id=info:doi/10.1016/S0165-5728(02)00430-7&rft_dat=%3Cproquest_cross%3E18687643%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c338t-c8454cc854137c070771cd427863f43b992eaa5f5fa833dc0a52448917b98b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18687643&rft_id=info:pmid/&rfr_iscdi=true